Search results
4 people applied for vacant seat on State College Borough Council. Hear from the candidates
State College Centre Daily Times via Yahoo News· 15 hours agoHayes, a borough resident of 15 years, in his application said he’s seen many changes in State...
Citi lifts AMC stock target to $3.20 as shares surge 175% in 2 days
Investing.com· 24 hours agoCiti lifts AMC stock target to $3.20 as shares surge 175% in 2 days
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 17 hours ago...terms or at all and other matters that could affect the availability or commercial potential of Aptevo's product candidates, business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises such as the coronavirus (referred to as COVID-19),...
Icahn Enterprises L.P. Announces Upsizing and Pricing of Senior Notes
The Herald-News· 1 day agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today that it, together with Icahn Enterprises Finance Corp. (together with Icahn ...
Icahn Enterprises L.P. Intends to Offer New Senior Notes
The Herald-News· 2 days agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today that it, together with Icahn Enterprises Finance Corp. (together with Icahn ...
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
Digital Journal· 23 hours agoBIO101 (20-hydroxyecdysone), our lead drug candidate, is a small molecule in development for muscular (sarcopenia, phase 3 ready and Duchenne muscular dystrophy), respiratory (Covid ...
Earnings call: Afya reports robust growth and strategic acquisitions in Q1 2024 By Investing.com
Investing.com· 2 days agoAfya Limited (NASDAQ: NASDAQ:AFYA), a leading medical education group in Brazil, has reported a...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...